EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Beneficial Antioxidant Effects of Coenzyme Q10 in In Vitro and In Vivo Models of CDKL5 Deficiency Disorder

Manuela Loi iD, Francesca Valenti iD, Giorgio Medici, Nicola Mottolese iD, Giulia Candini iD, Angelica Marina Bove, Federica Trebbi, Luca Pincigher iD, Romana Fato iD, Christian Bergamini iD, Stefania Trazzi iD, Elisabetta Ciani iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26052204 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Manuela Loi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Neuromotor Sciences, University of Bologna, Piazza di Porta San Donato 2, 40126 Bologna, Italy. Hauptthemen laut MEDLINE: Ubiquinone, Antioxidants, Epileptic Syndromes, Protein Serine-Threonine Kinases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'università e della ricerca, Italian parent association "CDKL5 insieme verso la cura", #NEXTGENERATIONEU (NGEU).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CDKL5 deficiency disorder (CDD), a developmental encephalopathy caused by mutations in the cyclin-dependent kinase-like 5 (CDKL5) gene, is characterized by a complex and severe clinical picture, including early-onset epilepsy and cognitive, motor, visual, and gastrointestinal disturbances. This disease still lacks a medical treatment to mitigate, or reverse, its course and improve the patient’s quality of life. Although CDD is primarily a genetic brain disorder, some evidence indicates systemic abnormalities, such as the presence of a redox imbalance in the plasma and skin fibroblasts from CDD patients and in the cardiac myocytes of a mouse model of CDD. In order to shed light on the role of oxidative stress in the CDD pathophysiology, in this study, we aimed to investigate the therapeutic potential of Coenzyme Q10 (CoQ10), which is known to be a powerful antioxidant, using in vitro and in vivo models of CDD. We found that CoQ10 supplementation not only reduces levels of reactive oxygen species (ROS) and normalizes glutathione balance but also restores the levels of markers of DNA damage (γ-H2AX) and senescence (lamin B1), restoring cellular proliferation and improving cellular survival in a human neuronal model of CDD. Importantly, oral supplementation with CoQ10 exerts a protective role toward lipid peroxidation and DNA damage in the heart of a murine model of CDD, the Cdkl5 (+/−) female mouse. Our results highlight the therapeutic potential of the antioxidant supplement CoQ10 in counteracting the detrimental oxidative stress induced by CDKL5 deficiency.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

UbiquinoneAntioxidantsEpileptic SyndromesProtein Serine-Threonine KinasesSpasms, InfantileMuscle WeaknessAnimalsHumansMiceDisease Models, AnimalOxidative StressReactive Oxygen SpeciesDNA DamageFibroblastsCell ProliferationGlutathioneFemale

Stichwörter der Autor:innen

CDKL5 deficiency disordercoenzyme Q10mouse modeloxidative stress

Substanzen

UbiquinoneAntioxidantscoenzyme Q10Reactive Oxygen SpeciesProtein Serine-Threonine KinasesGlutathione

Autor:innen und Institutionen

  • Department of Biomedical and Neuromotor Sciences, University of Bologna, Piazza di Porta San Donato 2, 40126 Bologna, Italy.
  • Department of Pharmacy and Biotechnology, University of Bologna, Via Irnerio 42, 40126 Bologna, Italy.

ORCID-Profile: Manuela Loi, Francesca Valenti, Nicola Mottolese, Giulia Candini, Luca Pincigher, Romana Fato, Christian Bergamini, Stefania Trazzi, Elisabetta Ciani

Förderung

  • Ministero dell'università e della ricerca
  • Italian parent association "CDKL5 insieme verso la cura"
  • #NEXTGENERATIONEU (NGEU)
  • Ministry of University and Research (MUR), National Recovery and Resilience Plan (NRRP)
  • Italian parent association “CDKL5 insieme verso la cura”
  • Indena S.p.A.

Zitieren

APA

Loi, M., Valenti, F., Medici, G., Mottolese, N., Candini, G., Bove, A. M., Trebbi, F., Pincigher, L., Fato, R., Bergamini, C., Trazzi, S., & Ciani, E. (2025). Beneficial Antioxidant Effects of Coenzyme Q10 in In Vitro and In Vivo Models of CDKL5 Deficiency Disorder. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26052204

Vancouver

Loi M, Valenti F, Medici G, Mottolese N, Candini G, Bove AM, et al. Beneficial Antioxidant Effects of Coenzyme Q10 in In Vitro and In Vivo Models of CDKL5 Deficiency Disorder. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26052204

BibTeX
@article{Loi2025,
  author = {Loi, Manuela and Valenti, Francesca and Medici, Giorgio and Mottolese, Nicola and Candini, Giulia and Bove, Angelica Marina and Trebbi, Federica and Pincigher, Luca and Fato, Romana and Bergamini, Christian and Trazzi, Stefania and Ciani, Elisabetta},
  title = {Beneficial Antioxidant Effects of Coenzyme Q10 in In Vitro and In Vivo Models of CDKL5 Deficiency Disorder},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26052204}
}
Kostenlos starten →